Unknown

Dataset Information

0

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.


ABSTRACT:

Rationale

Ongoing efforts to improve pulmonary gene transfer thereby enabling gene therapy for the treatment of lung diseases, such as cystic fibrosis (CF), has led to the assessment of a lentiviral vector (simian immunodeficiency virus [SIV]) pseudotyped with the Sendai virus envelope proteins F and HN.

Objectives

To place this vector onto a translational pathway to the clinic by addressing some key milestones that have to be achieved.

Methods

F/HN-SIV transduction efficiency, duration of expression, and toxicity were assessed in mice. In addition, F/HN-SIV was assessed in differentiated human air-liquid interface cultures, primary human nasal epithelial cells, and human and sheep lung slices.

Measurements and main results

A single dose produces lung expression for the lifetime of the mouse (~2 yr). Only brief contact time is needed to achieve transduction. Repeated daily administration leads to a dose-related increase in gene expression. Repeated monthly administration to mouse lower airways is feasible without loss of gene expression. There is no evidence of chronic toxicity during a 2-year study period. F/HN-SIV leads to persistent gene expression in human differentiated airway cultures and human lung slices and transduces freshly obtained primary human airway epithelial cells.

Conclusions

The data support F/HN-pseudotyped SIV as a promising vector for pulmonary gene therapy for several diseases including CF. We are now undertaking the necessary refinements to progress this vector into clinical trials.

SUBMITTER: Griesenbach U 

PROVIDER: S-EPMC3530223 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Rationale</h4>Ongoing efforts to improve pulmonary gene transfer thereby enabling gene therapy for the treatment of lung diseases, such as cystic fibrosis (CF), has led to the assessment of a lentiviral vector (simian immunodeficiency virus [SIV]) pseudotyped with the Sendai virus envelope proteins F and HN.<h4>Objectives</h4>To place this vector onto a translational pathway to the clinic by addressing some key milestones that have to be achieved.<h4>Methods</h4>F/HN-SIV transduction efficie  ...[more]

Similar Datasets

| S-EPMC2889732 | biostudies-literature
| S-EPMC9304433 | biostudies-literature
| S-EPMC8665819 | biostudies-literature
| S-EPMC2994542 | biostudies-literature
| S-EPMC11357811 | biostudies-literature
| S-EPMC5579034 | biostudies-other
| S-EPMC8181588 | biostudies-literature
| S-EPMC3335058 | biostudies-literature
| S-EPMC11209056 | biostudies-literature
| S-EPMC6948855 | biostudies-literature